FDA Adds $24.2 Million To Unapproved Drug Initiative Scorecard

Two weeks after FDA officials attempted to explain how well the Center for Drug Evaluation and Research's unapproved drug initiative is working, the agency showed how actions often speak louder than words

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet